جست‌وجوی استاد و پژوهشگر

Ken S. Wongمشاهده پروفایل

دانشیار

• Health Economics
• Outcomes Research
• Pharmaceutical Pricing
• +۴ مورد دیگر

Ken S. Wong is an Associate Professor of Pharmaceutical and Health Economics at the University of Southern California School of Pharmacy. He serves as Director of the USC Mann Division of Healthcare and Biopharmaceutical Business, which oversees the Healthcare Decision Analysis and Biopharmaceutical Marketing graduate programs. Dr. Wong is also a Senior Scholar at the USC Leonard D. Schaeffer Center for Health Policy & Economics. Dr. Wong received his PharmD from the University of Southern California, MPH from the University of Massachusetts at Amherst, and Bachelor's degree from the University of California at Los Angeles. Prior to his academic career, he held leadership positions at Novartis Pharmaceuticals as director of health economics and outcomes research and director of managed healthcare, and previously held pharmacy leadership roles at Cigna, Caremark, HealthNet and UniHealth. He also served as an accreditation surveyor for the Joint Commission. His research focuses on innovations in healthcare access and pharmaceutical pricing, with expertise spanning Innovative Care Delivery Models, Health Economics & Outcomes Research, Managed Care, Market Access & Reimbursement, and Innovative Pricing Models. His scholarly work examines medication adherence, blood pressure control, healthcare decision analysis, and the economic impact of pharmaceutical treatments, particularly in chronic disease management. Dr. Wong has published extensively from 2006-2019 with research spanning hypertension management, diabetes care, COPD treatment, and healthcare systems analysis. His publications demonstrate a consistent focus on the intersection of pharmaceuticals, economics, and patient outcomes, with particular attention to care management processes, medication adherence, and healthcare policy implications. As an educator, Dr. Wong plays a key role in developing and leading graduate programs that prepare students for careers in healthcare decision analysis and biopharmaceutical marketing, bridging the gap between academic research and industry practice. His leadership in the Division of Healthcare and Biopharmaceutical Business has established USC as a center for innovative research in pharmaceutical economics and healthcare policy.

Åse Linnéمشاهده پروفایل

دانشیار

• Construction Industry Innovation
• Biotechnology Business Networks
• Project Management
• +۴ مورد دیگر

Åse Linné serves as Associate Professor in the Department of Civil and Industrial Engineering within Uppsala University's Faculty of Science and Technology. Her academic position combines industrial engineering expertise with construction management specialization, evidenced by her dual departmental affiliation in Industrial Engineering and Management. Her research spans construction industry innovation , biotechnology business networks , and resource interaction theory in temporary organizations. Key focus areas include: Digital transformation in built environments Project partnering strategies across construction projects China's biopharmaceutical development combining political steering and transnational networks Sustainable hospital construction through resource interaction perspectives Recent work demonstrates strong emphasis on Swedish construction innovation (2020-2024), particularly hospital projects and digital capabilities. Her publication record shows consistent output in top journals including Industrial Marketing Management , Construction Management and Economics , and The IMP Journal . Key trends reveal: Evolution from Chinese biotech studies (2004-2013) to Swedish construction innovation (2015-present) Increasing focus on sustainability and digital transformation in built environments Strong interdisciplinary approach bridging engineering, management, and policy perspectives Linné's collaborative work spans multiple institutions, with frequent co-authorship patterns indicating stable research partnerships. Her 2022 hospital sustainability research involved cross-departmental collaboration within Uppsala University.

• Animal cell culture engineering
• Therapeutic protein production
• Viral vector production for gene therapy
• +۵ مورد دیگر

Professor Gyun Min Lee is a faculty member in the Department of Biological Sciences at Korea Advanced Institute of Science and Technology (KAIST), where he leads the Animal Cell Engineering Lab. His research focuses on developing advanced mammalian cell systems for therapeutic protein and viral vector production through innovative engineering approaches. Dr. Lee earned his Ph.D. in Chemical Engineering from the University of Michigan, providing him with a strong foundation at the intersection of engineering principles and biological systems. His technical expertise spans from molecular biology to bioprocess engineering, enabling comprehensive solutions for biopharmaceutical production challenges. Professor Lee's research program centers on animal cell engineering for biopharmaceutical applications. His team utilizes synthetic biology approaches including artificial promoters and transcriptional regulation to develop improved mammalian cell lines. A major focus involves using CRISPR/Cas9 technology and site-specific gene integration to construct cell libraries for discovering novel engineering targets. Additional research areas include cell line development platforms, bioprocess optimization, apoptosis and autophagy studies in production cell lines, proteomic analysis of host cell proteins, and strategies for improving difficult-to-express protein production. Analysis of Professor Lee's recent publication record reveals a strong emphasis on genome editing technologies for cell line improvement, particularly using CRISPR-based screening methods in CHO and HEK293 cells. His work bridges fundamental molecular mechanisms with practical bioprocess applications, demonstrating consistent innovation in enhancing productivity while maintaining product quality in therapeutic protein manufacturing. The research shows increasing sophistication in systems-level approaches to cell engineering. Professor Lee actively mentors researchers in the Animal Cell Engineering Lab, guiding projects that address critical challenges in biopharmaceutical production. His research is supported by various funding sources focused on advancing cell engineering technologies for therapeutic applications. The Animal Cell Engineering Lab maintains state-of-the-art facilities for mammalian cell culture, genetic engineering, and bioprocess development. The lab collaborates extensively with both academic and industry partners to translate basic research findings into practical applications for the biopharmaceutical industry, contributing significantly to advancements in therapeutic protein and viral vector manufacturing.